The Global Carboplatin Market size is expected to witness a CAGR of 7.1% during the forecast period, 2018-2028. The North American region dominated the market in terms of revenue and is expected to retain its dominance until 2020. The Carboplatin Crystal segment accounted for the major share in 2018 due to increasing demand from developing countries such as China, India, Brazil, and Russia. Asia Pacific region is projected to be fastest-growing regional market due to the increasing number of cancer patients with high disposable income coupled with low levels of awareness about drug resistance among these patients leading them towards more expensive drugs like carboplatin which can combat drug resistance and reduce treatment costs at later stages.
Carboplatin is a chemotherapy drug that works like cisplatin, but it has fewer side effects. Carboplatin slows the growth of cancer cells in your body by stopping their division or making them die. It belongs to the platinum-based family of chemotherapy agents. It acts on dividing cells by arresting DNA replication in metaphase when it binds to an enzyme called topoisomerase II. This results in mitotic arrest and cell death due to apoptosis as well as intercalation into cellular nucleic acids. It's used to treat various cancers including ovarian cancer and testicular cancer. It's also used to treat people with lung cancer who have a type of non-small cell lung cancer that has certain changes in the EGFR gene.
On the basis of Type, the global carboplatin market is segmented into carboplatin crystal and carboplatin powder.
Carboplatin Crystal is a drug that contains carboplatin, which belongs to the platinum-based family of chemotherapy drugs. Carboplatin crystals are a more stable form of carboplatin that has been used for the treatment of various cancers like ovarian cancer, testicular cancer, and others. Carboplatin in crystal form can be dissolved by heating or reacting with acids to produce medicine that is liquid at room temperature.
Carboplatin Powder is a type of Carboplatin, which belongs to the group of platinum analogs. Like other chemotherapeutic agents that contain platinum as an active component, it has antitumor activity and may also inhibit DNA synthesis in bone marrow cells. It can be given as a single agent or in combination with radiation treatments to treat metastatic cancers that have spread from their original site(s) into nearby tissue.
On the basis of Application, the global carboplatin market is segmented into Carboplatin Injection and Others.
Carboplatin injection is used to treat certain types of cancer. Carboplatinum injections are usually given intravenously (into a vein) on an outpatient basis and may be repeated every three weeks for up to six months. Carboplatin injection is used to treat cancer. It works by stopping the growth of cells and slows down cancerous cell growth. The drug blocks both dividing normal cells and those that are already growing abnormally, which inhibits tumor development. Carboplatin can be given as an intravenous (IV) infusion or it can also be taken in pill form orally with water according to your doctor's instructions.
On the basis of Region, the global carboplatin market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
In the North American market, the US is leading due to a well-established pharmaceutical industry as well as government regulations on the safety of drugs which has helped in increasing patient access to these treatments. It’s followed by Canada and Mexico. The carboplatin injection segment accounted for more than 45% share of the North American market in 2018 owing to its high usage among cancer patients undergoing chemotherapy treatment against various types of cancers including breast cancer, ovarian cancer, or testicular disease.
Latin American regions are expected to exhibit significant growth during the forecast period from 2021-2028 driven by increased demand for anti-cancer therapies globally especially within emerging markets such as Brazil and Argentina.
China and India are expected to be the fastest-growing markets followed by Russia and South Korea in terms of revenue, during the forecast period from 2021-2028. The carboplatin injection segment accounted for more than 45% share of China’s market in 2018 owing to its high usage among cancer patients undergoing chemotherapy treatment against various types of cancers including breast cancer, ovarian cancer, or testicular disease.
The global carboplatin market is witnessing growth due to the increase in the use of anti-cancer therapies globally. China and India are expected to be the fastest-growing markets followed by Russia and South Korea, during the forecast period from 2021-2028. Increased awareness about cancer treatments across emerging economies such as Brazil and Argentina has triggered an increase in demand for anti-cancer therapies within these regions. The increasing number of patients using different types of medicines, including chemotherapy drugs such as carboplatin against various cancers like breast cancer or ovarian cancer is also driving the demand for this product over time.
Up Market Research published a new report titled “Carboplatin Sales Market research report which is segmented by Types (Carboplatin Crystal, Carboplatin Powder), By Applications (Carboplatin Injection, Others), By Players/Companies Teva, Fresenius Kabi, Mylan, Qilu, Taj Pharmaceuticals, Tecoland Corporation, Johnson Matthey, Heraeus Deutschland”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Carboplatin Sales Market Research Report |
By Type | Carboplatin Crystal, Carboplatin Powder |
By Application | Carboplatin Injection, Others |
By Companies | Teva, Fresenius Kabi, Mylan, Qilu, Taj Pharmaceuticals, Tecoland Corporation, Johnson Matthey, Heraeus Deutschland |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 216 |
Number of Tables & Figures | 152 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Carboplatin Crystal, Carboplatin Powder and By Application Carboplatin Injection, Others.
Some of the companies that are profiled in this report are:
Carboplatin Sales Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Carboplatin Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Carboplatin Sales Market Report:
Some other reports from this category!